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Abstract
Antigenicity of the peptide of ribosomal digest in Ehrlich ascites tumor was studied. The
peptide was purified by DEAE Sephadex A-50 column chromatography. The peptide was elec-
trophoretically basic, single, and 1.32 S20w sedimentation coefficient with poor content of tyro-
sine and phenylalanine. The maximum absorbancy was at 267 mµ. Mice and rabbits were im-
munized with the mixture of the purified peptide with Freund’s complete adjuvant. The inhibitory
effect of immune γ-globulin on the tumor growth was demonstrated in vitro cultured JTC-11 cells.
A single precipitin line was observed between rabbit antiserum and tumor cell extract of Ehrlich
ascites cells in ouchterlony double diffusion chamber and immunoelectrophoresis. The sedimen-
tation coefficient of the effective fraction in immune-serum was 17 S20w. The precipitin line was
observed at β2-γ region in immunoelectrophoresis.
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Antitumor activity in regional lymph node protein of mice trans-
planted with Ehrlich ascites tumor was reported (1). The antigenicity of
tumor low density lipoprotein was demonstrated in the previous experi-
ment, which was clarified that the phospholipids of low density lipoprotein
have an important role for the antibody formation (2).
In the present experiment, the specific peptide of the ribosome of
Ehrlich ascites tumor was studied, and the antitumor activity of the mouse
serum immunized with this peptide was demonstrated JTC-ll cells cultured
in vitro and immuno-diffusion technique.
MATERIALS AND METHODS
Materials: Albino dd mice were inoculated subcutaneously withJTC-
11 cells (3) as described previously (l). The tumors on the tenth day after
transplantation were extirpated, minced in Waring blender, and then
homogenized in a glass-Teflon homogenizer with 10 volumes of O. 05 M
Tris-HCl buffer containing 0.025 M KCl and 0.005 M MgC12, pH 7.6.
The homogenate was centrifuged twice at 12, 000 X g for 40 min. in a
Hitachi Ultracentrifuge Model 40P at 2°C, and the supernatant was
centrifuged at 50, 000 X g for 50 min. The precipitate was resuspended
with 20 ml of Tris-HCl buffer, and 8 % sodium desoxycholate was added
to give the final concentration of 0.8 %. The suspension was allowed to
stand for 2 hrs at room temperature, and centrifuged at 144, 000 xg for
1 hr. The precipitate, yellowish jelly, was crude ribosome. About 100 mg
of precipitate of crude ribosome was dialyzed in O. 005 M MgC12, sus-
pended in 10 ml of Tris-HCl buffer, and incubated with 15 mg of RNase
and 5 mg of DNase. Thus, ribosomal digest was obtained.
Preparation of Peptide: The ribosomal digest solution was fractionated
on DEAE Sephadex A-50 column (3 X 30 cm) with O. 05 M Tris-HCl buffer
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containing 0.025 M KCI and 0.005 M MgCI2, pH 7.6, and the elution
patterns were recorded at 280 m,a by the autorecording Toyo Uvicon.540
optical unit attached to Toyo Fraction Collector SF·200A as illustrated in
Fig. 2. The absorbancy of the fractionated peak was determined by (Model
Fig. 2 Chromatography of ribosomal digest on DEAE Sephadex A·50
A 20·ml sample was applied on a 3x30 cm column. Elution was done with 0.05M
Tris-HCI buffer containing 0.025 M KCI and MgClz, pH 7.6, and the peak I was
peptide, and the peak III was eluted by adding 0.5 M NaCI in the same buffer.
EPS-3, Hitachi UV-VIS-NIR) recording spectrophotometer (Model EPS-3,
Hitachi UV-VIS-NIR). The maximum absorbancy of the peptide from
ribosomal digest was 267 mll. as seen in Fig. 3. Peak I was the peptide of
ribosomal digest, and Peaks II and III were RNA, and the peak was
subjected to disc electrophoresis (4). The peptide was desalted by Sepha-
Fig. 3 Absorbancy of the peptide of tumor ribosomal digest
Maximum absorbance of the peptide (Peak I in Fig. 2) was observed at 267 mp..
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dex G-15 column, and was used for amino acid analysis (5). Protein con-
centration was determined by the colorimetric methed of LOWRY et al. (6),
and the nitrogen content was determined by the micro-Kjeldahl method.
Preparation of Antisera: One mg of the peptide was dissolved in 0.5
ml of saline. The peptide solution was mixed with one.half volume of
Freund's complete adjuvant after filtrating through a sterilized millipore
filter. The mixture was intraperitoneally injected to dd mouse, and one-
half volume of the mixture was subcutaneously added weekly for a
month. The mixture was injected to rabbit three times weekly. Four injec-
tions of 5 mgjml peptide were done into subcutis of foot and back and in
gluteal muscle. Test bleedings were carried out on the 5th day after the
last injection, and when the sera were satisfactory the animals were inject-
ed intravenously with 5 mg of peptide as a booster. One week later, the
rabbits were sacrificed, and the sera were kept at -20°C after addition
of merthiolate to make a final concentration 1/5,000.
Cell Culture Test: The antitumor activity of immune serum of mice
was examined by cell culture technique, and, that of the supernatant of
lymph nodes and spleen homogenate was also tested as described pre-
viously (I).
Precipitin Reaction of Antisera and Immuno.electrophoresis: Precipitin reac-
tion of anti-serum was performed by the OUCHTERLONY'S technique (7),
and immuno-electrophoresis was carried out by the micro-method (8).
TABLE 1 AMINO ACID COMPOSITION
OF THE PEPTIDE IN TUMOR
RIBOSOMAL DIGEST
A 5-mg of the lyophilized
peptide was treated according
to MOORE et ai. (5), and was
analyzed on YANAGIMOTO auto-
recording analyzer, Model Le·5.
RESULTS
Chemical Characters: Ultracentrifugal
analyses of purified ribosome and the pep-
tide from ribosomal digest of Ehrlich ascites
tumor are shown in Fig. 1. The sedimenta-
tion constant was I. 32S20w, and the molecu-
lar weight was presumed about 6,000. Disc
electrophoresis, OUCHTERLONY'S double dif-
fusion and immuno-electrophoresis of the
peptide are shown in Fig. 4. The electro-
phoretic mobility of the peptide was more
basic than that of serum IgG. In these photo-
graphs, the peptide from ribosomal digest
was demonstrated to be single and probably
specific for Ehrlich ascites tumor cells.
Amino acid components of the peptide are
shown in Table 1. The contents of tyrosine
threonine
serine
glutamic acid
glycine
alanine
methionine
isolecine
leucine
tyrosine
phenylalanine
lysine
histidine
4.4 %
8.4
6.7
30.7
4.0
3.6
2.2
3.1
1.8
1.8
27.6
5.8
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Fig. 1 Ultracentrifugal analyses
a) Purified tumor ribosome. The peak was observed at 3 min. of 31,820 rpm,
and its sedimentation coefficient was 75 SZOw.
b) Peptide of tumor ribosomal digest. The peak was observed at 15 min. of
60, 000 rpm, and its sedimentation coefficient was 1.32 SZOw.
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48 hrs
and phenylalanine residues were small quantities.
Cell Culture Test: Growth inhibitory effects of globulin fraction from
immune serum and the supernatant of lymph nodes and spleen homoge-
nate of immunized mice are shown in Fig. 5. The effects on the antitumor
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Fig. 5 Antitumor activity of immunoglobulins.
Normal mouse serum globulin, immune globulin, and the supernatant of immunized
lymph nodes and spleen homogenate were added each in protein concentration of
I mg/ml for each cell culture tube.
e=control, 6=normal mouse serum globulin, O=supernatant of lymph nodes
and spleen homogenate immunized with the peptide .of tumor ribosomal digest,
0=serum globulin immunized with the peptide of tumor ribosomal digest.
Fig. 4. Electrophoresis of the peptide
a) Disc electrophoresis
The peptide was analyzed on a disc gel column, and a sin3le band was observed
in the middle of the column.
b) Precipitin reaction of anti-serum
Single precipitin line was observed among ribosome, Ehrlich ascites tumor homo6e-
nate and rabbit anti-serum.
R = ribosome of Ehrlich ascites tumor, E = Ehrlich ascites tumor homogenate,
L = normal mouse liver homo6enate, C = normal mouse serum, RS = rabbit anti-
serum to ribosome peptide.
c) Immuno-electrophoresis
A single line was observed from (32 to ..., position.
Rs= rabbit anti-serum, P = peptide of tumor ribosomal digest.
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Fig. 6 Antigenicity and peptide
concentration immune globulin at 25th
day after immunization, obtained by
immunizing with various concentra-
tions of the peptide.
0=1 mg, 0=0.5 mg, 0=0.25 mg,
,6 = normal mouse serumglobulin,
.=control.
____~ ..__.._.~ __.~__L~ ._. -:'="'-;-_
24 48 hrs
Time of culture
control
Fig. 7 Antitumor actIvIty
and days after immunization
immune-serum was obtained on
various days after immuniza-
tion, and each 1 mg/ml protein
concentration was added for cell
culture tube.
d=days after immunization
'"~
u
24
Time of culture
48 hrs
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activity of the peptide concentration used as antigen and the days after
immunization are shown in Figs. 6 and 7. Sera at the 25th day immunized
by 1 mg peptide were found to have the highest antitumor activity. The
growth inhibitory effect was mostly exist in r-globulin (Fig. 8).
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Fig. 8 Antitumor actIvIty of immune. 'Y-globulin aM, ,a- or 'Y-globulin of
immune-serum was added for cell culture tube. Immune-serum was fractionated
on DEAE Sephadex A-50 column, and I mg/ml protein concentration of each aM,
,a- and 'Y-globulin fraction was added for cell culture tube.
Titer of Antiserum and Antigenicity of Peptide: The titer of antiserum and
antigenicity of the peptide were determined by ouchterlony's technique, as
seen in Fig. 9. Precipitin line was observed in 24-fold dilution. Antigeni-
city was tested by multiple dilution of the peptide solution in ouchterlony
double diffusion chamber, and a sharp precipitin line was observed at
0.5 mg/ml protein concentration. Quantitative precipitin reaction was
carried out according to HEIDELBERGER and KENDALL (9), and the results
are shown in Fig. 10. The equivalent zone of antibody was inclined to
yield antibody excess.
Ultracentrifugal Analysis of r·Clobulin: r-Globulin of rabbit anti-serum
was chromatographed on Sephadex G-200 column (l. 5 x 120 cm), and
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the first elution peak was analyzed in
a Hitachi Analytical Ultracentrifuge
Model UCA-I as shown in Fig. II.
The sedimentation coefficient was
17.05 S20W.
DISCUSSIONS
MITCHINSON (0), ROSENAU (1)
and KLEIN (2) revealed the cellular
antibody for cancer, a'nd in the pre-
vious report (I), the possibility of
Fig. 9 Titer of anti-serum and anti-
genicity of peptide
a) Titer of anti-serum
P = peptide of tumor ribosomal digest. 4,
8, 16, and 32=Numbers of fold dilution
of rabbit anti-serum
b) Titer of antigen
RS=rabbit anti-serum, A= 1 m.s/ml of
the peptide from tumor ribosomal digest,
B = 0.5 mg/ml of the peptide, C=0.25
mg/ml of the peptide, D = 0.125 mg/ml
of the peptide.
10 20 30 40 50.ug
Nitrogen of the peptide added to 0.5 ml of rabbit anti-serum
Fig. 10 Quantitative precipitin reaction
Quantitative precipitin reaction was determined by total nitrogen of the precipitate.
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Fig. 11 Ultracentrifugal analysis of the effective fraction of rabbit anti-serum
A peak was observed at 16 min. of 60,000 rpm, and its sedimentation coefficient
was 17.05 S2Ow.
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antibody formation for malignant tumor was demonstrated. KORNGOLD
(13), PINKOWSKI (4) and ZILBER (15) reported the existence of cancer
specific antigen by precipitin reaction. HIRAI also reported the cancer
specific antigen of rat ascites Hepatomas (16).
In the present experiment, the antigenicity of the peptide obtained
from the rIbosome of Ehrlich ascites tumor was proved by in vitro cultured
JTC-ll cells, and the specificity by precipitin reaction. The peptide from
tumor ribosome was electrophoretically single with the absorbancy of 267
mp.. Immuno-electrophoresis and precipitin reaction showed to be specific
for Ehrlich ascites cells, but the contamination of nucleic acid cannot be
excluded. The content of tyrosine and phenylalanine was small quantities
in the amino acid components of the peptide. It is the well-known evidence
that tyrosine has an important role for antibody formation (7). The fact
indicates the difficulty of antibody formation by the peptide from riboso-
mal digest of Ehrlich ascites tumor, which was observed in weak sensitivity
of the precipitin reaction (Figs. 9, 10).
The ribosome is a manufacture unit of protein synthesis of the cell
08, 19). If cancer cell has a specific protein or antigen, the peptide of
the ribosome may have specificity for the cancer cell. In the previous
experiment, the antigenicity of low density lipoprotein in JTC-ll cells was
9
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demonstrated. Low density lipoprotein is a structure factor of membrane
in the cell (20, 21). Therefore, it is considered in the immunological stand
point of view that the cancer cells have two kinds of cell-specificities, one
is in the membrane structure and the other in the peptide structure of
ribosome. These two kinds of specificities might be occupying a small
part of the cancer cell. Therefore, the antibody formation for malignant
tumor was difficult, and spontaneous healing of cancer was rarely observed.
In the present experiment, the possibility of antibody formation for
malignant tumor was demonstrated, and the existence of Ehrlich ascites
cell-specific antigen was also clarified.
CONCLUSIONS
Antigenicity of the peptide of ribosomal digest in Ehrlich ascites
tumor was studied. The peptide was purified by DEAE Sephadex A-50
column chromatography. The peptide was electrophoretically basic, sin-
gle, and 1.32 S20w sedimentation coefficient with poor content of tyrosine
and phenylalanine. The maximum absorbancy was at 267 m,a. Mice and
rabbits were immunized with the mixture of the purified peptide with
Freund's complete adjuvant. The inhibitory effect of immune r-globulin
on the tumor growth was demonstrated in vitro cultured lTC-II cells. A
single precipitin line was observed between rabbit antiserum and tumor
cell extract of Ehrlich ascites cells in ouchterlony double diffusion chamber
and immunoelectrophoresis. The sedimentation coefficient of the effective
fraction in immune-serum was 17 S20w. The precipitin line was observed
at (32-1' region in immunoelectrophoresis.
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